Author:
Izumi-Nakaseko Hiroko,Nakamura Yuji,Cao Xin,Ohara Hiroshi,Yamazaki Yukiko,Ueda Naoya,Ando Kentaro,Sugiyama Atsushi
Funder
Ministry of Education, Culture, Sports, Science and Technology in Japan
Japan Science and Technology Agency
Toho University Graduate School of Medicine
Toho University Joint Research Fund
Reference36 articles.
1. Sources and sinks of activator calcium;Bers,2001
2. Dominant anti-vagal effect of pentobarbital on cardiac responses to intracardiac autonomic nerve stimulation in the dog;Chiba;Jpn. J. Pharmacol.,2001
3. The thorough QT study four years after the implementation of the ICH E14 guidance;Darpo;Br. J. Pharmacol.,2010
4. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (IKr) channel;Davie;J. Cardiovasc. Electrophysiol.,2004
5. Food and Drug Administration, 2005a. ICH Harmonised Tripartite Guideline, The Non-clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals S7B. Recommended for adoption at step 4 of the ICH process on 12 May 2005 by the ICH Steering Committee. ICH; 〈http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S7B/Step4/S7B_Guideline.pdf〉 (accessed 18.12.13.).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献